Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates - Wikidata - thesis-toulmin - TriplyDB

Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates

Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates

http://www.wikidata.org/entity/Q33613531

about

Vaccines against invasive Salmonella disease: current status and future directions Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development.Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence.Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.Evaluation of the Immunogenicity of Diphtheria Toxoid Conjugated to Salmonella Typhimurium-Derived OPS in a Mouse Model: A Potential Vaccine Candidate Against Salmonellosis A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned.Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.Molecular dynamics approach to probe the antigenicity of PagN - an outer membrane protein of Salmonella Typhi.Specific and cross-reactive plasmablast response in humans after primary and secondary immunization with Vi capsular polysaccharide typhoid vaccine.A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.Preparation and evaluation of immunogenic conjugates of Salmonella enterica serovar Typhi O-specific polysaccharides with diphtheria toxoid.The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.

P2860

Q27007088-478FE499-2841-498A-A640-5F79E4FF7CD3 Q27694492-D2D99967-072D-4C98-B11F-8212DBF6BF61 Q34179527-B0A1630A-B3F7-4A3B-B747-2445BA5FA452 Q34602404-4ED9EA44-D22A-4ADF-8FAC-C07CD4ED5147 Q34614158-3A087E23-0CDF-4524-8CA9-4C72B91209C7 Q35272921-91006CF1-3B1B-4B96-BCD5-FB62B3F90479 Q36184367-96FC13F3-5BAE-4462-80FD-C0A33C3D8354 Q37263373-8D058886-326D-4878-A88A-44F0C6D64EAF Q37340441-6F1DCBDD-357A-40D8-8D5D-48986CFC9004 Q38140038-128C01D0-4083-4800-AA45-D93F5725F13C Q38370291-5813EC5C-84C8-4AD7-BE25-FC33B54A81C0 Q40147988-E381B34D-6107-4F8D-A237-E159B37575F7 Q40291567-4AC991A5-5E25-46B9-931B-0DFC61D9FA73 Q40293025-FCC2111C-B79E-430F-B5BC-EFDD2C6BCC18 Q47245287-38C45B7E-65ED-41E2-86D9-769D0510F027

P2860

Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates

http://www.wikidata.org/entity/Q33613531

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Physical and chemical characte ...... e-diphtheria toxoid conjugates

@ast

Physical and chemical characte ...... e-diphtheria toxoid conjugates

@en

type

label

Physical and chemical characte ...... e-diphtheria toxoid conjugates

@ast

Physical and chemical characte ...... e-diphtheria toxoid conjugates

@en

prefLabel

Physical and chemical characte ...... e-diphtheria toxoid conjugates

@ast

Physical and chemical characte ...... e-diphtheria toxoid conjugates

@en

P1433

Q33613531-072DD9F3-93F3-45E2-AD0C-98B9AA4A5B20

P1476

Q33613531-3C1DA8CB-DB38-47A4-9A55-D14F33C13866

P2093

Q33613531-08E3C9D4-E344-44F5-BA7C-070C447481EC

Q33613531-08FD46C5-CD85-45ED-9AD8-7F913657B0B3

Q33613531-12BF3542-CA1A-435E-AC23-5B41F3072218

Q33613531-21FE85A3-25A0-4AEB-9514-9F1946111C31

Q33613531-4B22FE52-39D9-4B1B-9F0B-2B6A505FE2F9

Q33613531-69B852D2-F06D-4D99-BC57-5BCF0F560C4B

Q33613531-74AF709F-E166-478B-9467-B7B30094A927

P2860

Q33613531-01C436F4-1497-46D6-AE66-583C5062E8A7

Q33613531-05B16689-008A-45F9-9A1C-A15566D0C148

Q33613531-2AE482AC-ADD3-42F0-8390-77F13D4CFABC

Q33613531-2B8AEF74-A7AA-4BDB-8E96-8DE3C5EFA900

Q33613531-2CB0EF5B-6F69-41C1-8BA3-57EEA4FB6D5C

Q33613531-2E8CB522-F191-463C-968F-AE1D3BF635B7

Q33613531-31335BC6-76F8-4DE2-94F7-98C6650D7434

Q33613531-32DB52F5-C82A-4097-BE41-65EB7EC66DC5

Q33613531-33E192AD-D644-4D37-B1DD-29004E76840E

Q33613531-343E3937-E693-4055-BD1D-6DAA926F6556

P304

Q33613531-CE20C92D-1D22-492C-A352-74B2ACA716F6

P31

Q33613531-7EFE9D75-7703-4FB1-880A-AB2FF4E4C64E

P356

Q33613531-83A81DC6-98D4-4362-BC13-36E60EDD5AC5

P433

Q33613531-F1CBC7E8-79E9-422A-AC82-3B6502B496A5

P478

Q33613531-26CA86FE-3AA6-470C-9DEE-AAFCAC4C3828

P577

Q33613531-E4CDFA4C-35F4-4412-A3E1-683D8A1C5123

P698

Q33613531-36577FC7-9365-4894-B855-33BA8CFBCFC8

P921

Q33613531-6D9D9FEA-FD5C-4E8E-A72E-141F5AA63198

Q33613531-E5AF7002-4157-4C65-8509-027D9AB8F6E7

P932

Q33613531-0429F370-2801-44C5-932E-4FFA421D8AA3

P356

P1433

Clinical and Vaccine Immunology

P1476

Physical and chemical characte ...... e-diphtheria toxoid conjugates

@en

P2093

Cecil Czerkinsky

http://www.w3.org/2001/XMLSchema#string

Changfa Cui

http://www.w3.org/2001/XMLSchema#string

Hyun Jang

http://www.w3.org/2001/XMLSchema#string

John D Clemens

http://www.w3.org/2001/XMLSchema#string

Rodney Carbis

http://www.w3.org/2001/XMLSchema#string

Shousun C Szu

http://www.w3.org/2001/XMLSchema#string

So Jung An

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

The global burden of typhoid fever

Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice

Patterns of resistant Salmonella typhi infection in infants.

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.

Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine.

The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines.

Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.

P304

73-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00266-09

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19889941

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

Salmonella enterica

P932

2812100

http://www.w3.org/2001/XMLSchema#string